Kosaka T, Yamaguchi M, Miyanaga K, Mizuno K
Diagnostic Research and Development Department, R&D Division, Nesco Company, Azwell Inc., 2-24-3 Sho, Osaka 567-0806, Ibaraki, Japan.
Clin Chim Acta. 2001 Oct;312(1-2):179-83. doi: 10.1016/s0009-8981(01)00612-x.
A spectrophotometric assay for platelet-activating factor acetylhydrolase (PAF-AH) activity differs from the radioisotopic assay in its value because of a difference in substrate specificity. The spectrophotometric assay is more precise than the radioisotopic assay, providing information that is not clear with the radioisotopic assay.
We measured the serum PAF-AH activity in 3106 healthy Japanese, utilizing the spectrophotometric assay with an Hitachi 7170 automatic analyzer. We also measured the serum PAF-AH activity in 18 healthy volunteers to investigate the effect of diet and the change in activity in a day and over 6 weeks. Changes were examined at 0 (day 1), 1, 2, 4 and 6 weeks.
The mean value for females was significantly lower than that of males at the 5% level and both male and female activity had a tendency to increase with advancing age. It is known that the PAF-AH is primarily associated with LDL in blood and the PAF-AH activity correlated with the total cholesterol (r=0.52, n=126) and the LDL cholesterol (r=0.60, n=126) concentrations. In the diet study, there was no observable effect on activity. No difference in PAF-AH activity was observed between serum and plasma sample types. The serum PAF-AH activity was stable at 7 degrees C for at least 7 days and at -20 degrees C for at least 2 months.
The serum PAF-AH activity in women was lower than in men until the menopausal age was reached. We could use not only fresh fasting serum, but also plasma sample, non-fasting sample and stored sample to estimate the PAF-AH activity.
血小板活化因子乙酰水解酶(PAF-AH)活性的分光光度法测定与放射性同位素法测定的值不同,这是由于底物特异性存在差异。分光光度法比放射性同位素法更精确,能提供放射性同位素法无法明确的信息。
我们使用日立7170自动分析仪的分光光度法,测定了3106名健康日本人的血清PAF-AH活性。我们还测定了18名健康志愿者的血清PAF-AH活性,以研究饮食的影响以及一天内和6周以上的活性变化。在第0周(第1天)、第1周、第2周、第4周和第6周检查变化情况。
女性的平均值在5%水平上显著低于男性,并且男性和女性的活性均有随年龄增长而增加的趋势。已知PAF-AH主要与血液中的低密度脂蛋白相关,且PAF-AH活性与总胆固醇(r=0.52,n=126)和低密度脂蛋白胆固醇(r=0.60,n=126)浓度相关。在饮食研究中,未观察到对活性有明显影响。血清和血浆样本类型之间的PAF-AH活性未观察到差异。血清PAF-AH活性在7℃下至少稳定7天,在-20℃下至少稳定2个月。
在达到绝经年龄之前,女性的血清PAF-AH活性低于男性。我们不仅可以使用新鲜空腹血清,还可以使用血浆样本、非空腹样本和储存样本评估PAF-AH活性。